Source:http://linkedlifedata.com/resource/pubmed/id/19488918
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2010-6-21
|
pubmed:abstractText |
Imiquimod cream 5% is an immune modifier approved for the treatment of genital warts, actinic keratosis, and basal cell carcinoma. This case report presents an isolated case of telogen effluvium after 6 weeks of imiquimod treatment for an actinic keratosis on the scalp. Based on this case presentation, telogen effluvium is a potential rare side effect from imiquimod treatment.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1471-1753
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
21
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
122-4
|
pubmed:meshHeading |
pubmed-meshheading:19488918-Adjuvants, Immunologic,
pubmed-meshheading:19488918-Alopecia,
pubmed-meshheading:19488918-Aminoquinolines,
pubmed-meshheading:19488918-Biopsy,
pubmed-meshheading:19488918-Female,
pubmed-meshheading:19488918-Humans,
pubmed-meshheading:19488918-Keratosis, Actinic,
pubmed-meshheading:19488918-Middle Aged,
pubmed-meshheading:19488918-Ointments
|
pubmed:year |
2010
|
pubmed:articleTitle |
A case of imiquimod-induced alopecia.
|
pubmed:affiliation |
Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157-1071, USA.
|
pubmed:publicationType |
Journal Article,
Case Reports
|